Search clinical trials for: Triple Tracer Study
Total 121207 results
-
Skane University HospitalAC Immune SACompletedParkinson Disease | Multiple System Atrophy | Corticobasal Degeneration | Progressive Supranuclear Palsy | Dementia With Lewy BodiesSweden
-
Renske AltenaTerminatedHER2-positive Breast Cancer | Early-stage Breast CancerSweden
-
The Methodist Hospital Research InstituteBristol-Myers SquibbCompleted
-
University of OxfordUniversity College, London; Public Health EnglandCompleted
-
SanofiTerminatedTriple Negative Breast CancerSpain, Belgium, Italy, Czechia, Netherlands
-
Gilead SciencesCompleted
-
AbbVieCompletedCoronaVirus Disease-2019 (COVID-19)United States, Hungary, Israel, Netherlands, Puerto Rico
-
Eli Lilly and CompanyTerminatedHepatocellular Carcinoma | Solid Tumor | Gastric Adenocarcinoma | Leiomyosarcoma | Head and Neck Squamous Cell Carcinoma | Cervical Carcinoma | Triple-negative Breast Cancer | Undifferentiated Pleomorphic Sarcoma | High Grade Serous Ovarian CarcinomaUnited States, Japan
-
Baxalta now part of ShireCompletedPrimary Immunodeficiency Diseases (PID) | Hypogammaglobulinemia | AgammaglobulinemiaFinland, Sweden
-
Gilead SciencesWithdrawnTriple-negative Breast Cancer
-
University of Wisconsin, MadisonAvon FoundationTerminatedBreast Cancer | Triple Negative Breast CancerUnited States
-
Gilead SciencesCompletedCervical Cancer | Urinary Bladder Neoplasms | Small Cell Lung Cancer | Hepatocellular Carcinoma | Pancreatic Cancer | Esophageal Cancer | Ovarian Epithelial Cancer | Glioblastoma Multiforme | Gastric Adenocarcinoma | Triple Negative Breast Cancer | Endometrial Cancer | Non-small Cell Lung Cancer | Renal Cell Cancer and other conditionsUnited States
-
Novartis PharmaceuticalsCompletedMelanoma | Triple Negative Breast Cancer | Endometrial Carcinoma | Pancreatic CarcinomaUnited States, Germany, Italy, Japan, Belgium, Switzerland, Korea, Republic of, Hong Kong, Finland, France, Spain
-
Bristol-Myers SquibbJanssen Biotech, Inc.CompletedAdvanced CancerUnited States, Switzerland, France, Puerto Rico, Italy, Germany, Australia, Canada, Spain
-
GlaxoSmithKlineParexelCompletedPulmonary Disease, Chronic ObstructivePoland, United States, Russian Federation
-
Unidad de Investigación Genética MolecularUniversidad de AntioquiaCompleted
-
Eli Lilly and CompanyAurKa Pharma Inc.CompletedNeoplasms | Breast Neoplasms | Head and Neck Neoplasms | Small Cell Lung Carcinoma | Neoplasm Metastasis | Triple Negative Breast Neoplasms | Solid Tumor, AdultCanada
-
Novartis PharmaceuticalsCompletedAdvanced Triple Negative Breast Cancer (TNBC) With High TAMsFrance, Italy, Austria, Taiwan, United States, Spain, Australia, Korea, Republic of, Belgium, Germany, Hong Kong, Turkey
-
The George InstituteUniversity of SydneyTerminatedStroke | Hypertension | Cerebral Small Vessel Diseases | Vascular Dementia | Intracerebral HemorrhageAustralia
-
University of TorontoCompletedHealthy Adult MalesCanada
-
Priyanka SharmaCompletedTriple-negative Breast CancerUnited States
-
Curis, Inc.The Leukemia and Lymphoma SocietyCompletedLymphoma | Refractory Lymphoma | Relapsed Lymphoma | Relapsed and/or Refractory Lymphoma | Relapsed Ddiffuse Large B-Cell Lymphoma (DLBCL) | Refractory Diffuse Large B-Cell Lymphoma (DLBCL) | Relapsed and/or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) | Double-hit Lymphoma (DHL) | Triple-hit Lymphoma... and other conditionsUnited States
-
Baxalta now part of ShireCompletedImmune Thrombocytopenic Purpura (ITP)Poland, Hungary, Germany, Czechia
-
ChimerixWithdrawnAdvanced Colorectal Cancer | Advanced Glioblastoma | Advanced Triple-negative Breast Cancer | Advanced Non-small Cell Lung CancerUnited States
-
Boston PharmaceuticalsCompletedAdvanced Nonhaematologic MalignanciesUnited Kingdom
-
AstraZenecaParexelCompletedHealthy Volunteers (Intended Indication: Metastatic Patients With Triple Negative or HR+ Breast Cancer, or Hormone Sensitive Prostate Cancer)Germany
-
Gilead SciencesCompleted
-
The George InstituteUniversity of SydneyTerminatedHypertension | Cerebral Small Vessel Diseases | Dementia, Vascular | Stroke Hemorrhagic | Cognitive Decline | Intracerebral HemorrhageAustralia, Netherlands
-
GlaxoSmithKlineCompletedAsthmaAustralia, United States, Argentina, Canada, Germany, Japan, Korea, Republic of, Romania, Russian Federation, Spain, South Africa, Netherlands, Poland, Italy, United Kingdom
-
HiberCell, Inc.Merck Sharp & Dohme LLCCompletedAdvanced Melanoma | Triple-Negative Breast CancerUnited States
-
LegoChem Biosciences, IncCompletedHealthyKorea, Republic of
-
Taizhou Hanzhong biomedical co. LTDActive, not recruitingTriple-negative Breast CancerChina
-
Excited States, LLCVeristat, Inc.; Eurofins; Biotec Services International Ltd; CBR International...CompletedInfectionsUnited States, Israel
-
Dana-Farber Cancer InstituteNovartis; AstraZenecaCompleted
-
Merck Sharp & Dohme LLCTerminatedNon-small Cell Lung Cancer (NSCLC) | Triple Negative Breast Cancer (TNBC) | NUT Midline Carcinoma (NMC) | Castration-resistant Prostate Cancer (CRPC)
-
Oncoethix GmbHCompletedTriple Negative Breast Cancer | Pancreatic Ductal Adenocarcinoma | Castrate-resistant Prostate Cancer | CRPC | NUT Midline Carcinoma | Non-small Cell Lung Cancer With Rearranged ALK Gene/Fusion Protein or KRAS Mutation
-
AbbVieNSABP Foundation Inc; German Breast Group; US Oncology Research; Grupo Espanol...CompletedTriple Negative Breast CancerUnited States, Australia, Belgium, Canada, Czechia, France, Germany, Hungary, Italy, Korea, Republic of, Netherlands, Russian Federation, Spain, Taiwan, United Kingdom
-
Merck Sharp & Dohme LLCCompletedPneumococcal InfectionsUnited States, Australia, Canada, Chile, New Zealand, Poland, Russian Federation
-
Kathy MillerCompletedMetastatic Breast Cancer | Triple Negative Breast CancerUnited States
-
Abbott Medical DevicesCompletedHypertrophic Cardiomyopathy With ObstructionSpain
-
Novartis PharmaceuticalsCompletedMetastatic Colorectal Cancer | Gastric Cancer | Advanced Solid Tumors | Metastatic Breast Cancer | Gastroesophageal Junction Cancer | Recurrent Glioblastoma Multiforme | Advanced Pancreatic Adenocarcinoma | Safety | Triple Negative Metastatic Breast Cancer | Dose Escalation | Preliminary Efficacy | Hormone Receptor...Canada, United Kingdom, Spain, Germany, Italy, Belgium, Australia, United States
-
PfizerCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Novartis PharmaceuticalsCompletedAdvanced and Selected Solid TumorsBelgium, Spain, Canada, Switzerland, United States
-
Arbeitsgemeinschaft medikamentoese TumortherapieTakedaTerminatedTriple-Negative Breast CancerAustria
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8 | Prognostic Stage III Breast Cancer AJCC v8 | Prognostic Stage IIIA Breast Cancer AJCC v8 | Prognostic Stage IIIB Breast... and other conditionsUnited States
-
OHSU Knight Cancer InstituteOregon Health and Science University; Prospect Creek FoundationCompletedAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast CarcinomaUnited States
-
Hoffmann-La RocheTerminatedTriple Negative Breast Cancer | Advanced Ovarian CancerUnited Kingdom, United States, Australia, Denmark, Canada
-
Gilead SciencesCompletedHIV-1 InfectionUnited States, France, Austria, Germany
-
Incyte Biosciences International SàrlCompletedCervical Cancer | Hepatocellular Carcinoma | Esophageal Cancer | Ovarian Cancer | Mesothelioma | Non-small Cell Lung Cancer (NSCLC) | Urothelial Carcinoma | Merkel Cell Carcinoma | Diffuse Large B-cell Lymphoma | Triple-negative Breast Cancer | Renal Cell Carcinoma (RCC) | Small Cell Lung Cancer (SCLC) | Squamous... and other conditionsUnited States